Eagle Pharmaceuticals (NQ: EGRX )
5.705
-0.055
(-0.95%)
Streaming Delayed Price
Updated: 11:33 AM EDT, Jul 19, 2024
Add to My Watchlist
All News about Eagle Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2022/08/09/biotech7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/aapharma_5.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_540.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13166.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5848.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/04/SSI_baby_040417_shutter.jpg)
![](https://cdn.benzinga.com/files/short_image_95.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5241.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_4001.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3746.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2528.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2524.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech5_2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1240.jpeg)
![](https://mms.businesswire.com/media/20220201005079/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
February 01, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220131005051/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://mms.businesswire.com/media/20220118005359/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220105005918/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://mms.businesswire.com/media/20220103005456/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://mms.businesswire.com/media/20211229005303/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://mms.businesswire.com/media/20211220005628/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://mms.businesswire.com/media/20211215005960/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
December 15, 2021
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_393.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech_5.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884777_1920_0_5_20.jpg)
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20211122005873/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
November 09, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://mms.businesswire.com/media/20211109005935/en/657949/4/EAGLE_Logo_Blue_2018.jpg)
Eagle Pharmaceuticals Reports Third Quarter 2021 Results
November 09, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.